Cargando…

Molecular signatures of mu opioid receptor and somatostatin receptor 2 in pancreatic cancer

Pancreatic ductal adenocarcinoma (PDAC), a particularly aggressive malignancy, has been linked to atypical levels, certain mutations, and aberrant signaling of G-protein–coupled receptors (GPCRs). GPCRs have been challenging to target in cancer because they organize into complex networks in tumor ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jorand, Raphael, Biswas, Sunetra, Wakefield, Devin L., Tobin, Steven J., Golfetto, Ottavia, Hilton, Kelsey, Ko, Michelle, Ramos, Joe W., Small, Alexander R., Chu, Peiguo, Singh, Gagandeep, Jovanovic-Talisman, Tijana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society for Cell Biology 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5221597/ https://www.ncbi.nlm.nih.gov/pubmed/27682590 http://dx.doi.org/10.1091/mbc.E16-06-0427

Ejemplares similares

Dynamic lateral organization of opioid receptors (kappa, mu(wt) and mu(N40D)) in the plasma membrane at the nanoscale level
por: Rogacki, Maciej K., et al.
Publicado: (2018)

Using quantitative single molecule localization microscopy to optimize multivalent HER2-targeting ligands
por: Wakefield, Devin L., et al.
Publicado: (2023)

A Platform To Enhance Quantitative Single Molecule Localization Microscopy
por: Golfetto, Ottavia, et al.
Publicado: (2018)

Single molecule localization microscopy coupled with touch preparation for the quantification of trastuzumab-bound HER2
por: Tobin, Steven J., et al.
Publicado: (2018)

Naltrexone blocks alcohol-induced effects on kappa-opioid receptors in the plasma membrane
por: Terenius, Lars, et al.
Publicado: (2023)

Heterodimerization of Mu Opioid Receptor Protomer with Dopamine D(2) Receptor Modulates Agonist-Induced Internalization of Mu Opioid Receptor
por: Vasudevan, Lakshmi, et al.
Publicado: (2019)

Nitro-benzylideneoxymorphone, a bifunctional mu and delta opioid receptor ligand with high mu opioid receptor efficacy
por: Olson, Keith M., et al.
Publicado: (2023)

An Emerging Role for the Delta Opioid Receptor in the Regulation of Mu Opioid Receptor Function
por: Rozenfeld, Raphael, et al.
Publicado: (2007)

Mu Opioid Receptor Actions in the Lateral Habenula
por: Margolis, Elyssa B., et al.
Publicado: (2016)

Ligand-Specific Regulation of the Endogenous Mu-Opioid Receptor by Chronic Treatment with Mu-Opioid Peptide Agonists
por: Murányi, Marianna, et al.
Publicado: (2013)

Activity of opioid ligands in cells expressing cloned mu opioid receptors
por: Gharagozlou, Parham, et al.
Publicado: (2003)

Mu Opioid Receptor Gene: New Point Mutations in Opioid Addicts
por: Dinarvand, Amin, et al.
Publicado: (2014)

Inhomogeneity Based Characterization of Distribution Patterns on the Plasma Membrane
por: Paparelli, Laura, et al.
Publicado: (2016)

Mu opioid receptor: from pain to glucose metabolism
por: Tudurí, Eva, et al.
Publicado: (2016)

Molecular Perspectives for mu/delta Opioid Receptor Heteromers as Distinct, Functional Receptors
por: Ong, Edmund W., et al.
Publicado: (2014)

δ-Opioid Receptor and Somatostatin Receptor-4 Heterodimerization: Possible Implications in Modulation of Pain Associated Signaling
por: Somvanshi, Rishi K., et al.
Publicado: (2014)

Characterizing Binding Interactions That Are Essential for Selective Transport through the Nuclear Pore Complex
por: Lennon, Kathleen M., et al.
Publicado: (2021)

Adaptation to Hypoxia May Promote Therapeutic Resistance to Androgen Receptor Inhibition in Triple-Negative Breast Cancer
por: Jinna, Nikita, et al.
Publicado: (2022)

Orvinols with Mixed Kappa/Mu Opioid Receptor Agonist Activity
por: Greedy, Benjamin M., et al.
Publicado: (2013)

Differential Stability of the Crystallographic Interfaces of Mu- and Kappa-Opioid Receptors
por: Johnston, Jennifer M., et al.
Publicado: (2014)

Biased Signaling of the Mu Opioid Receptor Revealed in Native Neurons
por: Ehrlich, Aliza T., et al.
Publicado: (2019)

Heteromerization Modulates mu Opioid Receptor Functional Properties in vivo
por: Ugur, Muzeyyen, et al.
Publicado: (2018)

Blocking mu-opioid receptors inhibits social bonding in rituals
por: Charles, S. J., et al.
Publicado: (2020)

Antagonists of the Mu-Opioid Receptor in the Cancer Patient: Fact or Fiction?
por: Belltall, Amparo, et al.
Publicado: (2022)

Functional selectivity of EM-2 analogs at the mu-opioid receptor
por: Piekielna-Ciesielska, Justyna, et al.
Publicado: (2023)

Somatostatin Decorated Quantum Dots for Targeting of Somatostatin Receptors
por: Hafez Abdellatif, Ahmed Abdelfattah, et al.
Publicado: (2018)

Versatile Functions of Somatostatin and Somatostatin Receptors in the Gastrointestinal System
por: Shamsi, Bilal Haider, et al.
Publicado: (2021)

Comparison of physicochemical properties and biological activities of opioid morphinans interacting with mu opioid receptors
por: Asim, Muhammad F, et al.
Publicado: (2008)

Role of kappa‐opioid and mu‐opioid receptors in pruritus: Peripheral and central itch circuits
por: Kim, Brian S., et al.
Publicado: (2022)

Alternative Pre-mRNA Splicing of the Mu Opioid Receptor Gene, OPRM1: Insight into Complex Mu Opioid Actions
por: Liu, Shan, et al.
Publicado: (2021)

The mu opioid receptor and the orphan receptor GPR151 contribute to social reward in the habenula
por: Allain, Florence, et al.
Publicado: (2022)

The Sigma 2 receptor promotes and the Sigma 1 receptor inhibits mu-opioid receptor-mediated antinociception
por: Sánchez-Blázquez, Pilar, et al.
Publicado: (2020)

Mu opioid receptor activation enhances regulator of G protein signaling 4 association with the mu opioid receptor/G protein complex in a GTP‐dependent manner
por: Santhappan, Rema, et al.
Publicado: (2015)

Localisation of somatostatin and somatostatin receptors in benign and malignant ovarian tumours
por: Hall, G H, et al.
Publicado: (2002)

Exploration of Somatostatin Binding Mechanism to Somatostatin Receptor Subtype 4
por: Börzsei, Rita, et al.
Publicado: (2022)

Somatostatin receptor scintigraphy in sarcoidosis
por: Kamphuis, Lieke SJ, et al.
Publicado: (2011)

Comment on: Somatostatin receptor SPECT
por: Hubalewska-Dydejczyk, Alicja, et al.
Publicado: (2012)

Naloxegol: First oral peripherally acting mu opioid receptor antagonists for opioid-induced constipation
por: Anantharamu, Tejus, et al.
Publicado: (2015)

Mu opioid receptors on vGluT2‐expressing glutamatergic neurons modulate opioid reward
por: Reeves, Kaitlin C., et al.
Publicado: (2020)

Interactions Between Opioids and Dextroamphetamine on Locomotor Activity: Influence of an Opioid's Relative Efficacy at the Mu Receptor
por: Smith, Mark A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_onuss41tt0m9re0eki3sahba8r